Literature DB >> 33404930

Effect of Different Nail Penetration Enhancers in Solid Lipid Nanoparticles Containing Terbinafine Hydrochloride for Treatment of Onychomycosis.

Fatma E Abobakr1, Sahar M Fayez2, Vivian S Elwazzan3, Wedad Sakran4.   

Abstract

Onychomycosis is considered a stubborn nail fungal infection that does not respond to conventional topical antifungal treatments. This study aimed to develop and characterize novel solid lipid nanoparticles (SLNs) formulae containing terbinafine HCl (TFH) and loaded with different nail penetration enhancers (nPEs). Three (nPEs) N-acetyl-L-cysteine, thioglycolic acid, and thiourea were used. Characterization of the prepared formulae was done regarding particle size, zeta potential, polydispersity index (PDI), entrapment efficiency (EE%), physical stability, in vitro release study, infrared (FT-IR), and their morphological structures. The selected formulae and the marketed cream Lamifen® were compared in terms of their antifungal activity against Trichophyton rubrum as well as their nail hydration and their drug uptake by the nail clippers. Thiourea was the nPE of choice; formulae (N2 and N8), with thiourea, were considered the optimum TFH SLNs containing nPEs. They were selected for their optimum particle size of 426.3 ± 10.18 and 450.8 ± 11.45 nm as well as their highest EE% of 89.76 ± 1.25 and 90.35 ± 1.33, respectively. The in vitro microbiological screening of the antifungal activity of these two formulae showed significantly larger zones of inhibition in comparison with the marketed product. The ex vivo screening of the drug uptake of the two selected formulae was significantly higher than that of the marketed product. The nPE formulae present a very promising option as they showed optimum physicochemical characterization with high antifungal activity and high drug uptake as well as good nail hydration effect.

Entities:  

Keywords:  ex vivo transungual drug uptake; nail penetration enhancers (nPEs); onychomycosis; solid lipid nanoparticles (SLNs); terbinafine HCl (TFH)

Year:  2021        PMID: 33404930     DOI: 10.1208/s12249-020-01893-9

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  23 in total

Review 1.  Ungual and transungual drug delivery.

Authors:  H N Shivakumar; Abhishek Juluri; B G Desai; S Narasimha Murthy
Journal:  Drug Dev Ind Pharm       Date:  2011-12-10       Impact factor: 3.225

2.  Influence of penetration enhancers and molecular weight in antifungals permeation through bovine hoof membranes and prediction of efficacy in human nails.

Authors:  D Miron; R Cornelio; J Troleis; J Mariath; A R Zimmer; P Mayorga; E E S Schapoval
Journal:  Eur J Pharm Sci       Date:  2013-08-30       Impact factor: 4.384

3.  Toenail onychomycosis treated with a fractional carbon-dioxide laser and topical antifungal cream.

Authors:  Eun-Hwa Lim; Hyeong-rae Kim; Young-Ok Park; Young Lee; Young-Joon Seo; Chang-Deok Kim; Jeung-Hoon Lee; Myung Im
Journal:  J Am Acad Dermatol       Date:  2014-03-18       Impact factor: 11.527

4.  Effect of hydration on the permeation of ketoconazole through human nail plate in vitro.

Authors:  Hemali B Gunt; Gerald B Kasting
Journal:  Eur J Pharm Sci       Date:  2007-08-28       Impact factor: 4.384

5.  Development and characterization of effective topical liposomal system for localized treatment of cutaneous candidiasis.

Authors:  Madhu Gupta; Amit K Goyal; Shivani Rai Paliwal; Rishi Paliwal; Neeraj Mishra; Bhuvaneshwar Vaidya; Devyani Dube; Sanjay K Jain; Suresh P Vyas
Journal:  J Liposome Res       Date:  2010-02-18       Impact factor: 3.648

Review 6.  Topical antifungal drugs for the treatment of onychomycosis: an overview of current strategies for monotherapy and combination therapy.

Authors:  R Baran; A Kaoukhov
Journal:  J Eur Acad Dermatol Venereol       Date:  2005-01       Impact factor: 6.166

7.  Ciclopirox delivery into the human nail plate using novel lipid diffusion enhancers.

Authors:  Farhaan Hafeez; Xiaoying Hui; Marc Selner; Bert Rosenthal; Howard Maibach
Journal:  Drug Dev Ind Pharm       Date:  2013-04-19       Impact factor: 3.225

Review 8.  Do fungi play a role in psoriatic nails?

Authors:  Jacek C Szepietowski; Joanna Salomon
Journal:  Mycoses       Date:  2007-11       Impact factor: 4.377

Review 9.  Optimal management of fungal infections of the skin, hair, and nails.

Authors:  Aditya K Gupta; Elizabeth A Cooper; Jennifer E Ryder; Karyn A Nicol; Melody Chow; Maria M Chaudhry
Journal:  Am J Clin Dermatol       Date:  2004       Impact factor: 7.403

10.  The prevalance, epidemiology and risk factors for onychomycosis in hemodialysis patients.

Authors:  Güven Kuvandik; Meryem Cetin; Gultekin Genctoy; Mehmet Horoz; Mehmet Duru; Cenk Akcali; Salim Satar; Ahmet A Kiykim; Hasan Kaya
Journal:  BMC Infect Dis       Date:  2007-08-30       Impact factor: 3.090

View more
  2 in total

1.  Printing Drugs onto Nails for Effective Treatment of Onychomycosis.

Authors:  Thomas D Pollard; Margherita Bonetti; Adam Day; Simon Gaisford; Mine Orlu; Abdul W Basit; Sudaxshina Murdan; Alvaro Goyanes
Journal:  Pharmaceutics       Date:  2022-02-19       Impact factor: 6.321

2.  The Unique Carboxymethyl Fenugreek Gum Gel Loaded Itraconazole Self-Emulsifying Nanovesicles for Topical Onychomycosis Treatment.

Authors:  Ali Alqahtani; Bhavana Raut; Shagufta Khan; Jamal Moideen Muthu Mohamed; Adel Al Fatease; Taha Alqahtani; Ali Alamri; Fazil Ahmad; Venkatesan Krishnaraju
Journal:  Polymers (Basel)       Date:  2022-01-14       Impact factor: 4.329

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.